Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial
- 110 Downloads
To evaluate the efficacy and safety of Chinese medicine (CM) plus Western medicine (WM) in the treatment of pediatric patients with severe hand, foot and mouth disease (HFMD) by conducting a prospective, controlled, and randomized trial.
A total of 451 pediatric patients with severe HFMD were randomly assigned to receive WM therapy alone (224 cases, WM therapy group) or CM [Reduning Injection (热 毒宁注射液) or Xiyanping Injection (喜炎平注射液)] plus WM therapy (227 cases, CM plus WM therapy group) for 7–10 days, according to a web-based randomization system. The primary outcome was fever clearance time, which was presented as temperature decreased half-life time. The secondary outcomes included the rate of rash/herpes disappearance within 120 h, as well as the rate for cough, runny nose, lethargy and weakness, agitation or irritability, and vomiting clearance within 120 h. The drug-related adverse events were also recorded.
The temperature decreased half-life time was 40.4 h in the WM therapy group, significantly longer than 27.2 h in the CM plus WM therapy group (P<0.01). Moreover, the rate for rash/herpes disappearance within 120 h was 43.6% (99/227) in the CM plus WM therapy group, significantly higher than 29.5% (66/224) in the WM therapy group (P<0.01). In addition, the rate for cough, lethargy and weakness, agitation or irritability disappearance within 120 h was 32.6% (74/227) in the CM plus WM therapy group, significantly higher than 19.2% (43/224) in the WM therapy group (P<0.01). No drug-related adverse events were observed during the course of the study.
The combined CM and WM therapy achieved a better therapeutic efficacy in treating severe HFMD than the WM therapy alone. Reduning or Xiyanping Injections may become an important complementary therapy to WM for relieving the symptoms of severe HFMD. (Registration No. NCT01145664)
Keywordshand foot and mouth disease Reduning Injection Xiyanping Injection Chinese medicine
Unable to display preview. Download preview PDF.
- 7.National Health and Family Planning Commission of the People's Republic of China. Report of epidemic situation of infectious disease in China from January of 2010 to January of 2011. Available at http://www.moh.gov.cn/publicfiles/ business/htmlfiles/mohjbyfkzj/s3578/201102/50646.htm.Google Scholar
- 9.National Health and Family Planning Commission of the People's Republic of China. Guideline for the diagnosis and treatment of hand foot and mouth disease, Beijing, China, 2010. Available at http://www.nhfpc.gov.cn/mohyzs/ s3586/201004/46884.shtmlGoogle Scholar
- 10.Xue B, Yao Z, Yu R. Studies on anti-EV71 virus activity of traditional Chinese medicine and its clinical application in treatment of HFMD. China J Chin Mater Med (Chin) 2011;36:3366–3370.Google Scholar
- 12.Mu Y, Chen X, Zhang A. Effect of Reduning Injection on HFMD in children: a randomized controlled trial. Chin J Integr Tradit West Med (Chin) 2011;31:1209–1212.Google Scholar
- 13.Li X, Zhang C, Shi Q, Yang T, Zhu Q, Tian Y, et al. Improving the efficacy of conventional therapy by adding andrographolide sulfonate in the treatment of severe hand, foot, and mouth disease: a randomized controlled trial. Evid Based Complement Alternat Med 2013;2013:316250.PubMedPubMedCentralGoogle Scholar
- 15.Pharmacopoeia Committee of People's Republic of China. Chinese pharmacopoeia. Beijing: Chemical Industry Press;2005.Google Scholar
- 17.Zu M, Zhou D, Gao L, Liu A, Du G. Evaluation of Chinese traditional patent medicines against influenza virus in vitro. Acta Pharmaceut Sinica (Chin) 2010;45:408–412.Google Scholar
- 18.Lu C, Liu X, Ding X, Chen X, Fan H, Liu Y, et al. A metabolomics profiling study in hand-foot-and-mouth disease and modulated pathways of clinical intervention using liquid chromatography/quadrupole time-of-flight mass spectrometry. Evid Based Complement Alternat Med 2013;2013:647452.PubMedPubMedCentralGoogle Scholar